Anxiety is common among breast-cancer survivors. This analysis examined the effect of a hypnotic relaxation therapy, developed to reduce hot flashes, on anxiety levels of female breast-cancer survivors. Anxiety was assessed using a numeric analog scale and the Hospital Anxiety and Depression Scale-Anxiety subscale. Significant reductions in anxiety were found from pre-to postintervention for each weekly session and were predictive of overall reductions in anxiety from baseline to after the last intervention. In this analysis, hypnotizability did not significantly predict for anxiety reductions measured before and after each session or from baseline to exit. These data provide initial support for the use of hypnotic relaxation therapy to reduce anxiety among breast-cancer survivors.
. Studies investigating the use of hypnosis in controlling anxiety in cancer patients found that hypnosis interventions significantly decreased anxiety (Genuis, 1995) . Research has shown that hypnosis is likely efficacious in the treatment of both state and trait anxiety; however, it is acknowledged that further randomized controlled trials are needed to solidify findings (Coelho, Canter, & Ernst, 2007; Hammond, 2010) . Overall, the current literature supports the use of hypnosis as a means of decreasing anxiety in a variety of health conditions. However, there remains a lack of information regarding the effectiveness of a hypnotic intervention on anxiety among breast-cancer survivors.
The current analysis utilizes data from a larger study in which we examined hypnotic relaxation therapy (Elkins, 2014a) as a treatment for hot flashes among breast-cancer survivors (Elkins et al., 2008) . The larger study demonstrated hot flashes decreased by an average of 68% over baseline. The full study methods, a description of the baseline sample, and the primary outcomes have been reported elsewhere (Elkins et al., 2011 (Elkins et al., , 2008 . The purpose of this secondary analysis was to investigate the effectiveness of hypnotic relaxation therapy (HRT) on self-reported anxiety among breast-cancer survivors. These data have not been previously analyzed or reported.
Method

Participants
Participants were recruited from the Scott and White Cancer Institute in Temple, Texas. After informed consent, recruited participants were randomly assigned to either the hypnotic relaxation therapy (HRT) intervention or a no-treatment control arm. Participant eligibility was based on age (at least 18 years), a history of primary breast cancer with no evidence of detectable disease, and the presence of at least 14 hot flashes per week for a period of at least 1 month. Further, participants were restricted to females with a life expectancy of greater than 6 months. Participants were screened for medical and psychological conditions that would preclude study participation. Women who had taken antihormonal agents for breast cancer (e.g., tamoxifen or raloxifene) for more than 1 month were deemed eligible to participate. No other concurrent hormonal or putative therapies, chemotherapy, treatments for hot flashes, or the use of hypnosis for any reason were allowed. Full eligibility criteria were reported by Elkins et al. (2008) .
Materials
Numeric visual analog scale for anxiety (NVAAS) . A numeric visual analog scale for anxiety rating consisted of a single-item numeric visual analog scale that consists of numbers (0-10) spaced equally and sequentially along a 100 mm horizontal axis on which participants indicate their current level of anxiety. Past research has indicated that this type of scale is an adequate, valid, and reliable measure of anxiety (Davey, Barratt, Butow, & Deeks, 2007; Maxwell, 1978; Williams, Morlock, & Feltner, 2010) . A numeric analog scale for anxiety is easy to administer and correlates well with other measures of anxiety (r = .64, p < .001, State Trait Anxiety Inventory-State (STAI-S); r = .46, p < .005, State Trait Anxiety Inventory-Trait (STAI-T); Elkins, Staniunas, Rajab, Marcus, & Snyder, 2004) .
Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A).
The HADS-A (Zigmond & Snaith, 1983) consists of seven items. The selfreport scale is a measure of participants' generalized anxiety and fear over the past week. It exhibits high internal consistency (α = .84-.90; Julian, 2011) and concurrent validity with other self-report measures of anxiety (r = ∼.80 with the General Health Questionnaire (GHQ), Beck's Depression Inventory (BDI), State Trait Anxiety Inventory (STAI), Clinical Anxiety Scale (CAS), and Symptom Checklist 90 Scale (SCL-90) measures of anxiety; Bjelland et al., 2002) . (SHCS) . The SHCS (Morgan & Hilgard, 1978 ) is a five-item measure of hypnotic responsiveness often used as a brief assessment tool in clinical settings (Woody & Barnier, 2008) . Administration takes approximately 25 minutes. The SHCS has been shown to be as reliable and valid as other longer measures of hypnotizability (Elkins, 2014a; Morgan & Hilgard, 1978) .
Stanford Hypnotic Clinical Scale
Procedure
After obtaining written informed consent, participants randomized to the HRT condition completed a demographic questionnaire and baseline measures (including the HADS-A). A research coordinator scheduled participants for five weekly hypnotic relaxation therapy (HRT) sessions. A numeric analog scale for anxiety was administered before and after each HRT session. The HADS-A was completed at baseline and end-of-study. The SHCS was completed by participants at the end-of-study by masters-or doctoral-level professionals who were not involved in delivery of the intervention. The intervention consisted of HRT for the reduction of hot flashes. HRT is a manualized intervention involving both structured and individualized hypnotic inductions and teaching patients self-hypnosis (Elkins, 2014a) . Hypnotic suggestions are targeted to symptom reduction. In the present study, suggestions were for a hypnotic state, relaxation, and mental imagery for coolness as well as calmness. The hypnotic intervention was delivered according to a treatment manual by a clinician with a doctoral degree in psychology who had completed training according to the guidelines outlined by Elkins and Hammond (1998) . HRT for each session included the following: a hypnotic induction; mental imagery for coolness; mental imagery and suggestions for relaxation; deepening hypnosis and dissociation from hot flashes; positive suggestions and imagery for the future; self-hypnosis; and the alert, "In a few moments, return to conscious alertness." A more detailed description of the procedures has been previously published (Elkins et al., 2008) .
Statistical analyses were conducted using SPSS v. 21.0 (IBM Corp, 2012). Student's dependent samples t tests and a trend analysis were used to analyze pre-to postintervention changes in anxiety for each HRT session and for overall change in anxiety from baseline to followup. Bivariate linear regression was used to determine if changes in self-reported anxiety from pre-to postintervention were predictive of overall declines of anxiety reported on the HADS-A. Regression analysis was also used to determine if hypnotizability (SCHS) scores were predictive of reductions in anxiety.
Results
Twenty-seven breast-cancer survivors were assigned to receive hypnotic relaxation therapy. Mean age for participants was 55.5 years (SD = 7.3) with a range of 42-60 years. The ethnicity of participants was Caucasian (n = 25) and Hispanic (n = 1). The majority of participants were married (77%) and reported a college education (69%). See Table 1 for complete demographic information. Data were missing on the current measures for 1 participant from the original sample and, therefore, were excluded from the analyses (n = 26). Appendix 1 shows the flow of participants from enrollment through study completion.
The average pretest anxiety score, as reported on a numeric analog scale for anxiety, was 3.83 (SD = 2.11) for the first HRT session. Table 2 summarizes the means and standard deviations of the average numeric analog anxiety scores for all five HRT sessions.
Changes in anxiety reported on a numeric analog scale were assessed for normality and skewed distributions and were found to be normally distributed. In a sample of 26 women, self-reported anxiety significantly decreased from pre-to postintervention, (p < .05; see Table 2 ). Figure 1 visually illustrates these reductions in self-reported anxiety for each HRT session.
As shown in Figure 2 , trend analysis indicated significant declines in pretest anxiety from HRT Session 1 to HRT Session 5, F(1, 125) = 4.06, Trend analysis of posttest anxiety ratings from HRT Session 1 to HRT Session 5 showed reductions yet were not found to be statistically significant, F(1, 125) = 2.05, p = .099 (see Figure 2 ). As Elkins et al. (2008) previously reported, HADS-A scores reduced significantly among participants receiving the intervention, F(2, 44) = 6.083, p < .005, η 2 = .217. Findings from the current study provide further support for reductions in HADS-A scores among 26 participants receiving five weekly sessions of HRT (Baseline Mean = 5.89, SD = 4.34; Endpoint Mean = 3.23, SD = 3.19, p < .004). A regression analysis of these participants showed declines in self-reported anxiety pre-to postintervention were predictive of anxiety reductions on the HADS-A from baseline to endpoint, R 2 = .15, p < .05. Hypnotizability as measured by the SCHS was analyzed as a possible moderator of change in self-reported anxiety. A bivariate regression analysis showed hypnotizability did not significantly predict for reductions in self-reported anxiety from pre-to postintervention, R 2 = .022, F(1, 23) = 0.51, p = .48, or as reported on the HADS-A, R 2 = .004, p = .77. Data were missing for 1 participant on the SHCS and were excluded from the analyses (n = 25). The intervention was well tolerated and there were no adverse events (Elkins et al., 2008) .
Discussion
Anxiety is common among breast-cancer survivors (Prokop, Bradley, Burish, Anderson, & Fox, 1991) . Anxiety disrupts and decreases quality of life, thereby becoming a barrier to complete recovery (Stark & House, 2000) . As rates of breast cancer increase, it is imperative that treatments be developed that address the negative sequelae of cancer diagnosis, treatment, and survivorship, including anxiety (Kahn, Ward, Watson, & Rose, 2010; Lebel et al., 2013) . Research has shown breast-cancer survivors are receptive to complementary therapies, such as mind-body therapies, and seek them out to counteract the accompanying side effects of cancer treatment and recovery (Hann, Baker, Denniston, & Entrekin, 2005; Matthews, Sellergren, Huo, List, & Fleming, 2007) .
The present analysis provides data to support that hypnotic relaxation therapy (HRT) may be useful in reducing self-reported anxiety among breast-cancer survivors. Using hypnosis to treat anxiety among breast-cancer patients is an attractive option in that it poses little risk to the patient, has low patient burden and is cost effective. Hypnosis is usually reported as a pleasant experience, has few (if any) known side effects and does not interact with medications. Additionally, once a patient becomes familiar with hypnosis, it may be generalized to help with other distressing symptoms.
The effect sizes in this study were found to be large, but it has been reported that the use of a pretest-posttest design, such as that used in this study, may inflate effect sizes (Matt & Navarro, 1997) . Also, future research utilizing objective physiological measures of anxiety are needed to fully verify the anxiety-reducing capabilities of HRT (Vande Vusse, Hanson, Berner, & White Winters, 2010) .
Although the effects of HRT show promise for the reduction of anxiety among breast-cancer survivors, larger randomized controlled studies are needed to determine if these results are robust. Also, because the HRT in the current study was specifically intended to address hot flashes, further investigation is warranted to better understand if anxiety reductions were independent of the reductions in hot flashes also experienced by participants receiving HRT. A future study should consider anxiety as the primary measure, both subjectively and objectively and should include an active control group, such as structured attention, thereby providing control for attention, time, self-report bias, and other demand characteristics that could confound results.
Although hypnotizability has been found to moderate the effect of hypnosis on hot flashes (Elkins et al., 2011) , in the present study, it did not moderate reductions in anxiety among breast-cancer survivors. In the present study, HRT was effective in reducing anxiety regardless of hypnotic ability. Although hypnotizability may play a role in altering a physical symptom (such as hot flashes), reduction of emotional symptoms (such as anxiety) may be largely dependent on relaxation. It is noteworthy that declines in self-reported anxiety preto postintervention were predictive of anxiety reductions as measured on the HADS-A. This suggests that the initial response to hypnotic induction with reduction in anxiety may be a positive indicator of later endpoint reduction in self-reported anxiety.
There is a need for effective treatments of anxiety among breastcancer survivors that have low patient burden and are cost effective and safe. Hypnotic relaxation therapy shows promise as such a treatment; yet, more randomized controlled trials are needed before definitive conclusions can be drawn. In order to provide the best care possible to those recovering from the effects of breast cancer, it is imperative that these treatments be researched and developed further so that they may be disseminated to those in need of them. 
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Reducción de ansiedad en sobrevivientes de cáncer de mama bajo tratamiento hipnótico de relajación para bochornos Alisa J. Johnson, Joel Marcus, Kimberly Hickman, Debra Barton, y Gary Elkins Resumen: La ansiedad es común en sobrevivientes de cáncer de mama. Este análisis examinó el efecto de una terapia hipnótica de relajación, desarrollada para reducir bochornos en niveles de ansiedad en sobrevivientes de cáncer de mama. La ansiedad se evaluó mediante una escala numérica análoga y la subescala de ansiedad de la Escala de Ansiedad y Depresión Hospitalaria. Se encontraron reducciones significativas entre el pre y post-intervención para cada sesión semanal y fueron predictivas de las reducciones totales de ansiedad de la línea basal hasta el final de la última intervención. En este análisis, la hipnotizabilidad no predijo significativamente las reducciones de ansiedad medidas antes y después de cada sesión ni de la línea basal al término del tratamiento. Estos datos proveen sustento inicial para el uso de la terapia de relajación hipnótica para reducir ansiedad entre sobrevivientes de cáncer de mama.
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